Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Prada redefines youthful elegance with psychedelic flair

Jun 18, 2018

MILAN — Youthful designers injected energy into the third day Sunday of Milan Fashion Week menswear previews for next spring and summer. While the topics of generational and creative change at some of the most-established Milan fashion houses were running in the background, young brands carved out their own space to grow by their own rules. Some highlights from Sunday's shows, including Milan mainstay Prada alongside younger brands Palm Angels, MSGM, Sunnei and Korean newcomers BESFXXK. ___ PRADA BASICS Miuccia Prada says she was "trying to do elegant in a new young way" with her latest menswear collection. At Prada,...

From Missoni to Dolce&Gabbana, Milan men bask in street wear

Jun 18, 2018

MILAN — Milan designers continue to cast their eyes toward Millennials with a focus on street wear — but without giving up tailored luxury and technical innovations. Menswear collections for next spring and summer were being shown Saturday during the second day of Milan Fashion Week. The focus is increasingly on elements that can play up into office looks or down into casual street wear, using the same basic building blocks. The approach allows the designers to reach across generations, geographies and income levels. "Street wear is a way of dressing," said Angela Missoni, creative director of the eponymous fashion...

Zegna couture opens Milan Fashion Week against arched facade

Jun 18, 2018

MILAN — Not just trends, but also continuity, were in focus as Milan Fashion Week launched four days of menswear previews for next spring and summer on Friday. Fashion Week opened with the news that the Italian investment fund FSI has invested 70 million euros ($81 million) in the family-run Missoni fashion house, an important signal that home-grown funds were willing to pony up cash to help iconic brands make the generational transition. Meanwhile, Bottega Veneta announced the appointment of 32-year-old British designer Daniel Lee as its creative director, replacing Tomas Maier, the German designer who helped make ready-to-wear integral...

Family-owned Missoni sells 41.2 percent stake for expansion

Jun 18, 2018

MILAN — The family-owned Missoni fashion house announced Friday that Italian investment fund FSI will take a 41.2 percent stake in the firm to help expand the business and help usher the house toward an eventual public listing. Creative director Angela Missoni said the family will retain a 58.8 percent stake and operational control of the knitwear brand known for its intricate weaves and colorful designs. The outside investment will allow the company — founded by her parents 65 years ago and now in involving also the third generation — to look to the future, "safeguarding both our family unity...

Designer Louboutin wins case on red soled high-heels

Jun 18, 2018

LUXEMBOURG — The European Union's top court has defended French fashion designer Christian Louboutin's claim to trademark red soled high-heel shoes. The European Court of Justice ruled Tuesday that Van Haren, a Dutch company that sold similar shoes, had infringed the trade mark. The court said that it did not matter that its shoes were different in shape. It said the registration of the trademark "sought solely to protect that application of a colour to a specific part of that product." Louboutin said in a statement that it "warmly welcomes this judgment."

Search News

Sign up now!